Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function
Annals of Rheumatic Diseases, 11/09/09
Gerl V et al. – The phenotypic and migratory disturbances observed in SLE blood DCs could result in altered distribution of DCs in peripheral tissues, contributing to dysregulated immune responses and autoimmunity.
Methods- Plasmacytoid DCs (pDCs), myeloid DCs (mDCs) and monocytes from SLE patients, healthy volunteers, and healthy volunteers immunized with tetanus/diphtheria examined by flow cytometry for expression of subset specific antigens (BDCA-2, CD11c, CD14, HLA-DR), activation/maturation markers (CD83, CD86, CD40, BLyS) and chemokine receptors (CCR1, CCR5, CCR7, ChemR23)
- Migratory capacity to chemokine receptors investigated in vitro using chemokines RANTES, CCL19 and chemerin
- SLE monocytes and myeloid DCs had higher CD86 and BLyS expression levels
- ChemR23 expression lower in SLE plasmacytoid and myeloid DCs (p = 0.03). Basal (p= 0.004) and CCL19-specific migration levels (p=0.004) were higher in SLE plasmacytoid DCs
- Altered DC function in SLE had no correlative changes in chemokine receptor expression whereas immunization-induced blood DC migration patterns in healthy donors accompanied by changes in chemokine receptor expression
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
Musculoskeletal manifestations in patients with malignant disease
Clinical Rheumatology, 11/13/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Today in Systemic Lupus (SLE)...keeping you current
Receive free subspecialty "5-minute updates" via email
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial
Annals of Rheumatic Diseases, 11/10/09
Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/11/09
Sponsor
Article Search
Sponsor


See Latest Articles


